Covid-19: Novavax vaccine shows 89% efficacy in UK trials

Today’s opportunity: Significant automation gains  When leaders respond to immediate panic, new business risks and mitigations often emerge.  Two...

Vaccine makers have also struggled because HIV kills the very immune cells meant to stop infection. But a decade...

But there are tens of thousands of Chinese characters, and a 5-by-7 grid was too small to make them...

To support MIT Technology Review’s journalism, please consider becoming a subscriber. “It’s a great concept. I think it’s long...